Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$6.25 – $6.99
68% from low
No one on the platform currently holds NEUE.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 56,263 | $417.5K |
No one on the platform has traded NEUE yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $900M | +7.0% | $0.77 | $0.77–$0.77 | 8.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-11-06 | $-2.42 | $-6.78 | -180.2% |
| 2025-08-07 | $-4.77 | $-1.68 | +64.8% |
| 2025-05-08 | $-4.18 | $-1.80 | +56.9% |
| 2025-03-20 | $-2.29 | $-7.41 | -223.6% |
| 2024-11-07 | $-2.72 | $-6.78 | -149.3% |
| 2024-08-07 | $-3.26 | $-6.42 | -96.9% |
| 2024-05-08 | $-5.30 | $-2.31 | +56.4% |
| 2024-03-06 | $-4.16 | $20.07 | +582.5% |
| $61M |
| — |
| NAKANakamoto Inc. | $4.93 | -2.38% | $86M | — |
| OMICSingular Genomics Systems, Inc. | $20.01 | +0.00% | $51M | — |
Source: Financial Modeling Prep · peers by sector/industry
$BARK When a company is going private, the restricted shares must be converted and be sold. Also, any convertible notes must be paid. BARK is doing both. The convertible notes were paid and Matt Meeker has reported yesterday the sale of 36,206 shares from restricted shares: "The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a Restricted Stock Units award. Not an open market sale of securities." To confirm it, check $NEUE. AFTER the go-private deal, they did the same. Here in BARK they are doing it before any deal. This indicates that Matt Meeker is certain the company will have a deal to go private, soon. https://www.sec.gov/Archives/edgar/data/1819574/000185864626000004/xslF345X05/wk-form4_1771880625.xml
View on StockTwits ↗$NEUE that’s funny, despite commentary warning or questioning the tender validity, my account was credited the full $7.33 a share….
View on StockTwits ↗$NEUE surprise 😳 no warning just boom delisted buyout 7.33. on to the next abi
View on StockTwits ↗$NEUE Delisted. $7.33 paid out! Don't believe these clowns on here..
View on StockTwits ↗$NEUE Outstanding article that hits the mark on NEUE's current state. So if you want to refresh your NEUE insights or learn about NEUE from scratch, this is a must read. https://beyondspx.com/quote/NEUE/analysis/neuehealth-neue-a-value-based-transformation-on-the-cusp-of-privatization
View on StockTwits ↗$NEUE 🤣 did you claim your free money 💰 already? This is not about being positive, is called a scam, management's been sketchy since the beginning, making ebitda promises, then when it seems bagholders could eventually break even they decided to go private ??? Sure... keep waiting in line for your 7.33...
View on StockTwits ↗$NEUE knock knock, no we are not, it was just a trick, there's no free lunch for bagholders...
View on StockTwits ↗$NEUE There's clowns and this guy, who cannot even spell correctly a stock, never posted about WULF but WOLF... I guess some people did not have enough education... good luck with your bags
View on StockTwits ↗$NEUE he post bearish with $sobr $WULF then sobr upper 17% wulf upper 18%
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.